Skip to main content
Log in

Bisphosphonates of value for glucocorticoid recipients

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. van Staa TP, Geusens P, Zhang B, Leufkens HGM, Boonen A, Cooper C.Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids. Rheumatology 46: 460-466, No. 3, Mar 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bisphosphonates of value for glucocorticoid recipients. Pharmacoecon. Outcomes News 527, 1 (2007). https://doi.org/10.1007/BF03309396

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03309396

Keywords

Navigation